1201 related articles for article (PubMed ID: 19301378)
41. [Systematic reviews of treatment for chronic inflammatory demyelinating neuropathy].
Hughes RA
Rev Neurol (Paris); 2002 Dec; 158(123):32-36. PubMed ID: 12690331
[TBL] [Abstract][Full Text] [Related]
42. Treatment of chronic immune-mediated neuropathies: impact of the rare diseases centers network in Italy.
Nobile-Orazio E
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S33-8. PubMed ID: 23452770
[TBL] [Abstract][Full Text] [Related]
43. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
Comi G; Quattrini A; Fazio R; Roveri L
Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
[TBL] [Abstract][Full Text] [Related]
44. [The clinical usefulness of high-dose intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy].
Kubori T; Mezaki T; Kaji R; Kimura J; Hamaguchi K; Hirayama K; Kanazawa I; Miyatake T; Mannen T; Kowa H; Yanagisawa N; Goto I; Osame M; Kanda M; Tashiro K; Baba M; Kuroiwa Y; Nagatomo H; Mitsuma T; Shigeta Y; Saida T; Nakajima K; Kawamura J; Murai Y; Kiuchi T
No To Shinkei; 1999 Feb; 51(2):127-35. PubMed ID: 10198901
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
Magy L; Kaboré R; Mathis S; Lebeau P; Ghorab K; Caudie C; Vallat JM
J Immunol Res; 2015; 2015():450391. PubMed ID: 26065001
[TBL] [Abstract][Full Text] [Related]
46. Subcutaneous versus intravenous immunoglobulin for chronic autoimmune neuropathies: A meta-analysis.
Racosta JM; Sposato LA; Kimpinski K
Muscle Nerve; 2017 Jun; 55(6):802-809. PubMed ID: 27649063
[TBL] [Abstract][Full Text] [Related]
47. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
[TBL] [Abstract][Full Text] [Related]
48. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
49. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
Lunn MP; Nobile-Orazio E
Cochrane Database Syst Rev; 2012 May; (5):CD002827. PubMed ID: 22592686
[TBL] [Abstract][Full Text] [Related]
50. [Autoimmune neuropathies: diagnosis, treatment, and recent topics].
Ueda M; Kusunoki S
Brain Nerve; 2011 Jun; 63(6):549-55. PubMed ID: 21613658
[TBL] [Abstract][Full Text] [Related]
51. Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA
Drugs; 2009 May; 69(8):987-1001. PubMed ID: 19496628
[TBL] [Abstract][Full Text] [Related]
52. Treatment of inflammatory and paraproteinemic neuropathies.
Monaco S; Turri E; Zanusso G; Maistrello B
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):141-8. PubMed ID: 15180454
[TBL] [Abstract][Full Text] [Related]
53. Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome.
Viala K; Renié L; Maisonobe T; Béhin A; Neil J; Léger JM; Bouche P
Brain; 2004 Sep; 127(Pt 9):2010-7. PubMed ID: 15289267
[TBL] [Abstract][Full Text] [Related]
54. Rituximab in chronic immune mediated neuropathies: a systematic review.
Chaganti S; Hannaford A; Vucic S
Neuromuscul Disord; 2022 Aug; 32(8):621-627. PubMed ID: 35672205
[TBL] [Abstract][Full Text] [Related]
55. [Fisher syndrome and Bickerstaff brainstem encephalitis].
Kuwabara S
Rinsho Shinkeigaku; 2014; 54(12):1056-7. PubMed ID: 25672708
[TBL] [Abstract][Full Text] [Related]
56. Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy".
Berger AR; Herskovitz S; Kaplan J
Muscle Nerve; 1995 Apr; 18(4):440-4. PubMed ID: 7715630
[TBL] [Abstract][Full Text] [Related]
57. Antibody-associated polyneuropathy syndromes: principles and treatment.
Kornberg AJ; Pestronk A
Semin Neurol; 2003 Jun; 23(2):181-90. PubMed ID: 12894383
[TBL] [Abstract][Full Text] [Related]
58. Distal acquired demyelinating symmetric neuropathy associated with anti-GM1 antibodies: is this a CIDP variant?
Remiche G; Kentos A; Mavroudakis N
Acta Neurol Belg; 2010 Mar; 110(1):103-6. PubMed ID: 20514936
[TBL] [Abstract][Full Text] [Related]
59. A diagnostic score for anti-myelin-associated-glycoprotein neuropathy or chronic inflammatory demyelinating polyradiculoneuropathy in patients with anti-myelin-associated-glycoprotein antibody.
Doneddu PE; Ruiz M; Bianchi E; Liberatore G; Manganelli F; Cocito D; Cosentino G; Benedetti L; Marfia GA; Filosto M; Briani C; Giannotta C; Nobile-Orazio E
Eur J Neurol; 2023 Feb; 30(2):501-510. PubMed ID: 35191144
[TBL] [Abstract][Full Text] [Related]
60. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
